The 19 references in paper S. Ovcharenko I., С. Овчаренко И. (2014) “Фенотипы больных хронической обструктивной болезнью легких и исследование ECLIPSE: первые результаты // Phenotypes of chronic obstructive pulmonary disease and the ECLIPSE study: preliminary results” / spz:neicon:pulmonology:y:2011:i:3:p:113-117

1
Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких. (Федеральная программа): Практическое руководство для врачей. 2-е изд. М.; 2004. Рис. 2. Фенотип ХОБЛ, проявляющийся частыми обострениями [19] На рис. 2 и 3 – данные ECLIPSE за 3 года; на столбцах указано количество пациентов. Рис. 3. Фенотип ХОБЛ, не проявляющийся обострениями [19]
(check this in PDF content)
2
Buist S., McBurnie, Vollmer W.M. et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741–750.
(check this in PDF content)
3
Celli B.R., MacNee W., Agusti A.G. et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS position paper. Eur. Respir. J. 2004; 23: 932–946.
(check this in PDF content)
4
Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176 (6): 532–555.
(check this in PDF content)
5
Committee for proprietary medicinal products points to consider on clinical investigation of medicine products in the chronic treatment of patients with COPD. London; 1999. 562–598.
(check this in PDF content)
6
Jones P.W., Agusti A. Outcomes and markers of chronic obstructive pulmonary disease. Eur. Resp. J. 2006; 27: 822–832.
(check this in PDF content)
7
Cazzola M., MacNee W., Martinez F.J. et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur. Respir. J. 2008; 31: 416–469.
(check this in PDF content)
8
Han MeiLan K., Agusti A., Calverely P. et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am. J. Respir. Crit. Care Med. 2010; 182 (5): 598–604.
(check this in PDF content)
9
Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких. M.: Атмосфера; 2008.
(check this in PDF content)
10
Овчаренко С.И., Капустина В.А.Хроническая обструктивная болезнь легких: особенности у женщин. Пульмонология 2009; 2: 102–112.
(check this in PDF content)
11
Vestbo J., Anderson W., Coxson H.O. et al.Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoint (ECLIPSE). Eur. Respir. J. 2008; 31: 869–873.
(check this in PDF content)
12
Agusti A., Calverely P., Celli B. et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010; 11: 122.
(check this in PDF content)
13
Kanner R.E., Anthonisen N.R., Connett J.E. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 358–364.
(check this in PDF content)
14
Donaldson G.C., Seemungal T.A., Bhowmik A. et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847–852.
(check this in PDF content)
15
Donaldson G.C., Wilkinson T.M.A., Hurst J.R. et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.2005; 171: 446–452.
(check this in PDF content)
16
Seemungal T.A., Donaldson G.C, Paul E.A. et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157 (5, Pt 1):1418–1422.
(check this in PDF content)
17
Soler5Cataluna J.J., Martinez5Garcia M.A., Roman Sanchez P. et al.Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925–931.
(check this in PDF content)
18
Sullivan S.D., Ramsey S.D., Lee T.A. The economic burden of COPD*. Chest 2000; 117 (2, Suppl.): 5S–9S.
(check this in PDF content)
19
Hurst J.R., Vestbo J., Anzueto A. et al.Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010; 363: 1128–1138. Информация об авторе Овчаренко Светлана Ивановна– д. м. н., проф. кафедры факультет-
(check this in PDF content)